Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synergy CHC (SNYR) Cash & Equivalents (2016 - 2025)

Synergy CHC (SNYR) has 10 years of Cash & Equivalents data on record, last reported at $1.0 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 288.04% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $1.0 million, up 288.04%, while the annual FY2024 figure was $687920.0, 8.76% up from the prior year.
  • Cash & Equivalents reached $1.0 million in Q3 2025 per SNYR's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.5 million in Q2 2025 and bottomed at $177882.0 in Q1 2025.
  • Average Cash & Equivalents over 3 years is $703793.5, with a median of $660227.0 recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: increased 8.76% in 2024, then surged 288.04% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $632534.0 in 2023, then rose by 8.76% to $687920.0 in 2024, then soared by 46.31% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $1.0 million in Q3 2025, $1.5 million in Q2 2025, and $177882.0 in Q1 2025.